Company Filing History:
Years Active: 2024
Title: Guoyong Jia: Innovator in Biopharmaceuticals
Introduction
Guoyong Jia is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of non-alcoholic steatohepatitis (NASH). His innovative approach has garnered attention in the medical community.
Latest Patents
Guoyong Jia holds a patent for a method of treating NASH using a long-acting mutant human fibroblast growth factor. The invention involves administering a long-acting mutant human fibroblast growth factor, specifically mPEG-CH—NH-mFGF21, to a subject in need. This new use represents a promising advancement in the treatment of this condition.
Career Highlights
Jia is associated with Tasly Biopharmaceuticals Co., Ltd., where he continues to work on groundbreaking research and development. His expertise in biopharmaceuticals has positioned him as a key figure in the industry.
Collaborations
Some of his notable coworkers include Jian Li and Jun Han, who contribute to the innovative environment at Tasly Biopharmaceuticals Co., Ltd.
Conclusion
Guoyong Jia's work exemplifies the spirit of innovation in the biopharmaceutical sector. His contributions to the treatment of NASH highlight the importance of research and development in improving patient outcomes.